InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,591.96
(
0.00%
)
US TECH 100
18,872.40
(
0.10%
)
Dow Jones
41,335.05
(
0.59%
)
Brent Oil
78.95
(
0.23%
)
Bitcoin
59,210.07
(
-0.31%
)
Post# of 252990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 121071

Monday, 06/06/2011 1:02:42 PM

Monday, June 06, 2011 1:02:42 PM

Post# of 252990
ARIA / INCY:

I think both those NDAs are a go.

INCY has clear efficacy so that should help ease any concerns about a new class of drug getting on the market. ARIA has efficacy and a bit of a rough safety profile, but that is a class effect that the FDA should be aware of.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up